Trial By Error: A Short Talk for UK Docs and Researchers
…I assume they would, if released, cause some embarrassment, given the many flaws that marred the published paper. Two years ago, more than 100 experts from around the world signed…
…I assume they would, if released, cause some embarrassment, given the many flaws that marred the published paper. Two years ago, more than 100 experts from around the world signed…
…the ideological brigades.) ********** Questions from their own data Beyond that, their own data raise some questions about the second sentence. In this case, they found a very low prevalence…
…are investigating whether anti-viral antibodies are the key. A major assumption of these studies, and indeed of most of the vaccines in development, is that antibodies to the SARS-CoV-2 spike…
Results on efficacy of the first of the SARS-CoV-2 candidate vaccines has been announced by Pfizer this week. The company states that the viral spike-encoding mRNA vaccine candidate was found…
…“low” or “very low.” If an “evidence-based” treatment is based on evidence of very low quality, the treatment itself is also likely to be of very low quality. In that…
…or even develop new symptoms, after acute SARS-CoV-2 infection? What is the underlying biological cause of these prolonged symptoms? What makes some people vulnerable to this but not others? Does…